Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.44 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.43 |
| ▸ | TP53 | P04637 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5547838 | 1.00 | MEN1 (0.44) | MEN1KMT2ANPC1RAB9ATAS1R3 | |
| SCHEMBL5552059 | 0.88 | SMN1; SMN2 (0.47) | MEN1KMT2ANPC1RAB9ATAS1R3 | |
| SCHEMBL5551925 | 0.87 | RAB9A (0.49) | MEN1KMT2ANPC1RAB9ATAS1R3 | |
| SCHEMBL5551994 | 0.86 | MEN1 (0.45) | MEN1KMT2ANPC1RAB9ATAS1R3 | |
| SCHEMBL5659278 | 0.86 | MEN1 (0.45) | MEN1KMT2ANPC1RAB9ATAS1R3 | |
| SCHEMBL5551480 | 0.82 | TAS1R3 (0.52) | MEN1KMT2ANPC1RAB9ATAS1R3 | |
| SCHEMBL5551469 | 0.80 | MEN1 (0.49) | MEN1KMT2ANPC1RAB9ATAS1R3 | |
| SCHEMBL30729579 | 0.79 | ALDH1A1 (0.52) | MEN1KMT2ANPC1RAB9ATAS1R3 | |
| SCHEMBL21749699 | 0.79 | ALDH1A1 (0.52) | MEN1KMT2ANPC1RAB9ATAS1R3 | |
| SCHEMBL5547809 | 0.79 | ALDH1A1 (0.50) | MEN1KMT2ANPC1RAB9ATAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070244153-A1 | Diamine Derivative, Process of Preparation Thereof, and Fungicide Comprising Diamine Derivative as an Active Ingredient | MITSUI CHEMICALS, INC. (JP) | 2007-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244153-A1 | Diamine Derivative, Process of Preparation Thereof, and Fungicide Comprising Diamine Derivative as an Active Ingredient | DDT, AOC1, QDPR | MEN1 779/4885KMT2A 460/4885NPC1 4508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.